THE EFFICACY OF PEMETREXED-BASED TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC), AS CORRELATED WITH THE PATHOLOGIC FEATURES OF TUMORS

被引：0
|
作者：
Shiran, I. [1 ]
Borshteen, R. [1 ]
Urban, D. [1 ]
Onn, A. [1 ]
Biran, H. [1 ]
Bar, J. [1 ]
机构：
[1] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [31] Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study
    Lei, Lei
    Wang, Wen-Xian
    Zhu, You-Cai
    Pu, Xing-Xiang
    Fang, Yong
    Wang, Hong
    Zhuang, Wu
    Zhang, Yin-Bin
    Wang, Li-Ping
    Xu, Chun-Wei
    Fang, Mei-Yu
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6039 - 6049
  • [32] Crizotinib versus pemetrexed-based chemotherapy in patients with advanced ROS1-rearranged non-small cell lung cancer.
    Shen, Lan
    Lu, Shun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [34] EGFR gene mutation as a predictive marker of the response to pemetrexed-based chemotherapy in non-small cell lung cancer
    Nobuyuki, Koyama
    Sadakata, Rinako
    Miyazawa, Hitoshi
    Hagiwara, Koichi
    Kobayashi, Kunihiko
    CANCER RESEARCH, 2011, 71
  • [35] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    LUNG CANCER, 2002, 38 : S47 - S50
  • [36] Significance of glucocorticoid receptor expression in patients with non-small cell lung cancer treated with pemetrexed-based chemotherapy
    Xin-min Zhao
    Jing Zhao
    Xiang-hua Wu
    Zhi-guo Luo
    Hui-jie Wang
    Hui Yu
    Jian-hua Chang
    Jia-lei Wang
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 851 - 860
  • [37] Meta-Analysis Examining Impact of Age on Pemetrexed (pem) Efficacy for the Treatment of Advanced Nonsquamous (NS) Non-Small Cell Lung Cancer (NSCLC)
    Paz-Ares, L. G.
    Zimmermann, A.
    Ciuleanu, T. E.
    Bunn, P. A.
    San Antonio, B.
    Denne, J.
    Iturria, N.
    John, W.
    Scagliotti, G. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S43 - S43
  • [38] Significance of glucocorticoid receptor expression in patients with non-small cell lung cancer treated with pemetrexed-based chemotherapy
    Zhao, Xin-min
    Zhao, Jing
    Wu, Xiang-hua
    Luo, Zhi-guo
    Wang, Hui-jie
    Yu, Hui
    Chang, Jian-hua
    Wang, Jia-lei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (04) : 851 - 860
  • [39] Meta-analysis examining impact of age on pemetrexed (pem) efficacy for the treatment of advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis
    Zimmermann, Annamaria
    Ciuleanu, Tudor-Eliade
    Bunn, Paul A.
    San Antonio, Behan
    Denne, Jonathan
    Iturria, Nancy
    John, William J.
    Vittorio Scagliotti, Giorgio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer
    Ricciuti, B.
    Brambilla, M.
    Cortellini, A.
    De Giglio, A.
    Ficorella, C.
    Sidoni, A.
    Bellezza, G.
    Crino, L.
    Ludovini, V
    Baglivo, S.
    Metro, G.
    Chiari, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (05): : 708 - 716
12345